Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Axilum Robotics develops and commercializes robotic systems (TMS-Robot and TMS-Cobot) that automate and optimize coil positioning for transcranial magnetic stimulation procedures; TMS-Cobot is CE marked, has FDA 510(k) clearance in the USA, and regulatory approvals in Australia and Singapore, and is used clinically with MagVenture/MagVita TMS systems for treatment of major depressive disorder and for research TMS procedures.[1][2][3][4]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Axilum Robotics.